Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Sep 13, 2024
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Common Stock
2024-09-11$22.70/sh+22,026$499,990→ 131,426 total
Footnotes (1)
- [F1]Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024.